C Stöllberger, J Finsterer… - Expert review of … - pubmed.ncbi.nlm.nih.gov
Introduction Sodium glucoseco-transporter2-inhibitors (SGLT2-I), antihyperglycemic agents, are increasinglyprescribed in chronic heart failure (CHF). Their risk for drug-drug …
C Stöllberger, J Finsterer… - Expert Review of …, 2023 - europepmc.org
Sodium glucoseco-transporter2-inhibitors (SGLT2-I), antihyperglycemic agents, are increasinglyprescribed in chronic heart failure (CHF). Their risk for drug-drug interactions …